Condition: Urinary Bladder Neoplasms · Neoplasm Metastasis · Ureteral Neoplasms · Sponsor: Eli Lilly and Company
The main purpose of this study is to learn more about the safety, side effects, and effectiveness of LOXO-435 by itself or when it is combined with other standard medicines that treat cancer. LOXO-435 may be used to treat cancer of the cells that line the urinary system and other solid tumor cancers that have a change in a particular gene (known as the FGFR3 gene). Participation could last up to 30 months (2.5 years) and possibly longer if the disease does not get worse.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| University of Arizona - Cancer Center | Tucson, Arizona, United States | Recruiting |
| City of Hope | Duarte, California, United States | Recruiting |
| University of California, Los Angeles (UCLA) - Division of Hematology-Oncology | Los Angeles, California, United States | Recruiting |
| University of California - Irvine | Orange, California, United States | Recruiting |
| University of California (UC) Davis Comprehensive Cancer Center | Sacramento, California, United States | Recruiting |
| Stanford Medicine Cancer Center | Stanford, California, United States | Recruiting |
| Advent Health | Orlando, Florida, United States | Recruiting |
| Emory University Hospital | Atlanta, Georgia, United States | Recruiting |
| The University of Chicago Medical Center (UCMC) | Chicago, Illinois, United States | Recruiting |
| Indiana University (IU) Melvin and Bren Simon Cancer Center | Indianapolis, Indiana, United States | Recruiting |
| Mary Bird Perkins Cancer Center | Baton Rouge, Louisiana, United States | Recruiting |
| Ochsner Clinic Foundation | New Orleans, Louisiana, United States | Recruiting |
+ 70 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05614739